Dr. Darja Marolt, an Investigator at The New York Stem Cell Foundation (NYSCF) Laboratory, is lead author on a study showing that human embryonic stem cells can be used to grow bone tissue grafts for use in research and potential therapeutic application. Dr. Marolt conducted this research as a post-doctoral NYSCF Â– Druckenmiller Fellow at Columbia University in the laboratory of Dr. Gordana Vunjak-Novakovic.
A new study shows the neurophysiological impacts of psychotherapy
This press release is available in French.
Contrary to intuition, people who suffer from the motor and vocal tics characteristic of Tourette syndrome actually perform behavioral tests of cognitive motor control more accurately and quickly than their typically developing peers do. According to evidence reported online on March 24 in Current Biology, a Cell Press publication, that enhanced control arises from structural and functional changes in the brain that likely come about from the need to constantly suppress tics.
ST. PAUL, Minn. Â– A long term study reports about the effectiveness of replacing bone marrow, purposely destroyed by chemotherapy, with autologous (self) stem cell rescue for people with aggressive forms of multiple sclerosis (MS). The study is published in the March 22, 2011, print issue of NeurologyÂ®, the medical journal of the American Academy of Neurology.
New treatment options target underlying causes of childhood obsessive-compulsive and Tourette’s disorders
New Rochelle, NY, September 8, 2010Â—Pediatric-onset obsessive compulsive disorder (OCD) and Tourette’s disorder (TD) share similarities in their underlying genetic and environmental factors, psychiatric features, and treatment methods. Advances in understanding the neurobiological basis of these disorders and discovering new and more effective therapies are highlighted in a special issue on OCD and TD in Journal of Child and Adolescent Psychopharmacology, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com). The entire issue is available free online at www.liebertpub.com/cap
Understanding how blood stem cells are maintained within the niche offers new opportunities to exploit them therapeutically
Cold Spring Harbor, N.Y. Â– Hematopoietic stem cells (HSCs) have two unique abilities that are prized by medical researchers: to self-renew and to develop into any kind of blood cell, which enables them to replenish the entire blood and immune system. Scientists have traced these qualities to a distinct locale or niche within the bone marrow that HSCs home in on, but the identity and function of the niche-forming constituents have not been clearly defined.
Contact: Karen N.Peart
A single, very unusual family with Tourette syndrome (TS) has led Yale School of Medicine researchers to identify a rare mutation in a gene that is required to produce histamine. The finding provides a new framework to understand many years of data on the role of histamine function in the brain and points to a potentially novel approach to treatment of tics and Tourette.
Deep brain stimulation may be a safe and effective treatment for Tourette syndrome, according to research published in the October 27, 2009, print issue of NeurologyÂ®, the medical journal of the American Academy of Neurology.